|
rdfs:label
|
"Dolasetron"@de
"Dolasetron"@en-ca
"Dolasetron"@en-gb
"Dolasetron"@id
"Dolasetron"@ro
"Dolasetron"@sh
"Dolasetron"@sr
"Dolasetron"@tr
"Dolasetron"@vi
"Dolasetrona"@pt
"Dolasetrona"@pt-br
"Dolasetrón"@es
"dolasetron"@en
"dolasetron"@cy
"dolasetron"@fr
"dolasetron"@nl
"dolasetron"@pl
"dolasetron"@sl
"dolasetronum"@la
"dolasetró"@ca
"Доласетрон"@ru
"دولاسترون"@fa
"دولاسيترون"@ar
"ଡୋଲାସେଟ୍ରୋନ"@or
"多拉司琼"@zh
"多拉司琼"@zh-hans
"多拉司瓊"@zh-hant
|
|
skos:altLabel
|
"Anzemet Cinv"@cy
"ଆଞ୍ଜେମେଟ"@or
|
|
schema:description
|
"Arzneistoff"@de
"cheemesch Verbindung"@lb
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kemična spojina; učinkovina"@sl
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"médicament"@fr
"pharmaceutical drug"@en
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ଏହା ଏକ ଔଷଧ ଯାହା ଅସ୍ତ୍ରୋପଚାର ପରବର୍ତ୍ତୀ ଏବଂ କେମୋଥେରାପି ପ୍ରେରିତ ଅଇ ଏବଂ ବାନ୍ତି ଉପଶମ ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ।"@or
|
|
schema:dateModified
|
"2026-07-19T19:10:02+00:00"^^xsd:dateTime
|
|
schema:version
|
2519799075
|
|
wikibase:identifiers
|
28
|
|
wikibase:sitelinks
|
19
|
|
wikibase:statements
|
50
|
|
p:P10245
|
wd:statement/Q1829318-61050e3c-4b70-0e97-4f2b-2ad98630f1a9
|
|
wd:statement/Q1829318-d9e7ce6e-4935-f3bc-af3f-d3cb38576e91
|
|
p:P11089
|
wd:statement/Q1829318-D322054A-6997-420F-A450-1277879D7807
|
|
p:P11143
|
wd:statement/Q1829318-E74D2F8E-FED6-4F65-952D-1A0CCBEC1440
|
|
p:P11199
|
wd:statement/Q1829318-F03A9C12-ED2C-457C-BD0D-1369E37F811E
|
|
p:P117
|
wd:statement/Q1829318-65B3F20F-726C-40A8-8F13-9E189F184346
|
|
p:P129
|
wd:statement/Q1829318-DDBCE612-F73E-4218-84E3-DA849BCC8FB4
|
|
p:P1748
|
wd:statement/Q1829318-5454A387-8EE1-48FB-A2C1-5C6B5E095C99
|
|
p:P1889
|
wd:statement/Q1829318-862a15f5-4e39-fa49-ba1c-1bb79d58a327
|
|
p:P2017
|
wd:statement/Q1829318-15D45252-CDDA-45FA-9309-A755A990A40A
|
|
wd:statement/Q1829318-ADE943C6-028C-4C17-9F6E-0F34418F7BBA
|
|
p:P2062
|
wd:statement/Q1829318-12BC3856-3E04-4B53-A8B3-68BD36FDF9C3
|
|
p:P2067
|
wd:statement/Q1829318-12A6A97A-4C5C-49E4-A31E-DF507FD07955
|
|
p:P2115
|
wd:statement/Q1829318-7BB6C776-C6CD-46D4-9465-F904874B3109
|
|
p:P2175
|
wd:statement/Q1829318-BB920061-E32B-497E-AEA0-206A4DB987DF
|
|
p:P2275
|
wd:statement/Q1829318-4B8564D5-284C-448F-A78A-3E6A753FD5FA
|
|
p:P231
|
wd:statement/Q1829318-678C5E30-55E9-4D98-8EED-F84212ED20E1
|
|
p:P232
|
wd:statement/Q1829318-66A1578C-F316-43A9-B2D8-39D90AD38AF9
|
|
p:P233
|
wd:statement/Q1829318-2AB0FCC0-59DF-4633-A8F4-29B5D814995B
|
|
p:P234
|
wd:statement/Q1829318-EB774197-FB07-4E98-8040-ED92A9F2C8CB
|
|
p:P235
|
wd:statement/Q1829318-FEDCC405-0625-4D93-A838-F883CB2B4F5C
|
|
p:P2566
|
wd:statement/Q1829318-13572468-2468-1357-eca9-bdf024681357
|
|
p:P267
|
wd:statement/Q1829318-634E8C97-7C1F-40A8-8AE1-E655AE7DADC5
|
|
p:P274
|
wd:statement/Q1829318-0E70A203-54F1-45BA-B04A-16058B0094F4
|
|
p:P279
|
wd:statement/Q1829318-19C37D0F-47F4-4EAE-BE6F-242F5BA5E10E
|
|
p:P2868
|
wd:statement/Q1829318-05EE4D2C-5ED0-4695-AB40-E5A7E2344F55
|
|
wd:statement/Q1829318-64448A03-41FD-4CAF-B351-04845AC0C88F
|
|
p:P2877
|
wd:statement/Q1829318-01A34AE1-6700-4B43-9323-168C8D0CF103
|
|
p:P31
|
wd:statement/Q1829318-10E400DF-15D6-4B96-9DF2-3AD6EC2303EE
|
|
p:P3117
|
wd:statement/Q1829318-66157510-4724-4975-A06D-E55339DAF754
|
|
p:P3345
|
wd:statement/Q1829318-8DE89326-9F0B-4C9A-A911-0629A46FC0F2
|
|
p:P366
|
wd:statement/Q1829318-B90F393C-76A2-4F77-B95C-1766E868E0FF
|
|
p:P3780
|
wd:statement/Q1829318-26E389AC-1DE1-4BD6-B813-C11DC973382F
|
|
p:P4235
|
wd:statement/Q1829318-4FB4F875-19CE-4BE3-ABD2-3D63ED372179
|
|
p:P486
|
wd:statement/Q1829318-D841187B-B0D4-456F-A3ED-C49781D7D860
|
|
p:P527
|
wd:statement/Q1829318-3D184488-58C5-4984-AD0F-BBAE6BD2359D
|
|
wd:statement/Q1829318-E5CFB4C3-2299-42BF-9E2D-1447ABF36892
|
|
wd:statement/Q1829318-E75C1E3F-A924-4F6B-B8F1-477C6388D425
|
|
wd:statement/Q1829318-fb07c6b6-4575-0c10-273a-15e782a72d74
|
|
p:P592
|
wd:statement/Q1829318-97B76349-5D6C-49F9-A77E-E2645A4AFEEC
|
|
p:P6366
|
wd:statement/Q1829318-986522C4-5D93-4315-80A3-C9C51764D9C4
|
|
p:P646
|
wd:statement/Q1829318-58F32E51-BD08-43D7-9C32-0E1991271997
|
|
p:P652
|
wd:statement/Q1829318-256205FC-D8DF-4C1A-BB0E-B5B735F658E1
|
|
p:P661
|
wd:statement/Q1829318-38811697-2238-47D0-86C7-EB2D6DD9DACB
|
|
p:P662
|
wd:statement/Q1829318-1CDB18D9-02A7-4C82-8888-8B8452294EE5
|
|
p:P665
|
wd:statement/Q1829318-8AEF1801-0483-4E2C-8FC4-1A3AF5776F97
|
|
p:P683
|
wd:statement/Q1829318-F258FA5B-C0BB-4286-972C-A2CD9C7A29F5
|
|
p:P715
|
wd:statement/Q1829318-92B3A006-A5F3-41F0-9406-1888B1231C9D
|
|
p:P8224
|
wd:statement/Q1829318-72B15DEF-475F-4B8B-815B-F58424A25B0F
|
|
p:P8494
|
wd:statement/Q1829318-51D0DC04-B5A1-4A08-AD9A-AFC0B50CFC22
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000022087>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/C060344>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL2368925>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2777425725>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/30845229>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60654>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D07867>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_4682>
|
|
wdt:P10245
|
"a601001"
|
|
"a601214"
|
|
wdt:P11089
|
"1065860"
|
|
wdt:P11143
|
"Dolasetron"
|
|
wdt:P11199
|
"PD016336"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Dolasetron.svg>
|
|
wdt:P129
|
5-hydroxytryptamine receptor 3A
|
|
wdt:P1748
|
"C61735"
|
|
wdt:P1889
|
(6R,9aS)-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl 1H-Indole-3-carboxylate
|
|
wdt:P2017
|
"O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c4c[nH]c5ccccc45"
|
|
"O=C(O[C@H]1C[C@@H]2C[C@@H]3C[C@@H](C1)N2CC3=O)C4=CNC5=C4C=CC=C5"
|
|
wdt:P2062
|
"7565"
|
|
wdt:P2067
|
324.1473925^^xsd:decimal
|
|
wdt:P2115
|
"N0000022087"
|
|
wdt:P2175
|
vomiting
|
|
wdt:P2275
|
"dolasetron"@en
|
|
wdt:P231
|
"115956-12-2"
|
|
wdt:P232
|
"601-402-4"
|
|
wdt:P233
|
"O=C(OC1CC2CC3CC(C1)N2CC3=O)c1c[nH]c2ccccc12"
|
|
wdt:P234
|
"InChI=1S/C19H20N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,20H,5-8,10H2/t11-,12-,13+,14+"
|
|
wdt:P235
|
"UKTAZPQNNNJVKR-KJGYPYNMSA-N"
|
|
wdt:P2566
|
"100.130.141"
|
|
wdt:P267
|
"A04AA04"
|
|
wdt:P274
|
"C₁₉H₂₀N₂O₃"
|
|
wdt:P279
|
Anzemet
|
|
wdt:P2868
|
antiemetic
|
|
serotonin antagonist
|
|
wdt:P2877
|
"29356821"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID4048276"
|
|
wdt:P3345
|
"68091"
|
|
wdt:P366
|
medication
|
|
wdt:P3780
|
Anzemet
|
|
wdt:P4235
|
"dolasetron"
|
|
wdt:P486
|
"C060344"
|
|
wdt:P527
|
hydrogen
|
|
carbon
|
|
nitrogen
|
|
oxygen
|
|
wdt:P592
|
"CHEMBL2368925"
|
|
wdt:P6366
|
"2777425725"
|
|
wdt:P646
|
"/m/07tvvx"
|
|
wdt:P652
|
"82WI2L7Q6E"
|
|
wdt:P661
|
"30845229"
|
|
wdt:P662
|
"60654"
|
|
wdt:P665
|
"D07867"
|
|
wdt:P683
|
"4682"
|
|
wdt:P715
|
"DB00757"
|
|
wdt:P8224
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Dolasetron%203D.png>
|
|
wdt:P8494
|
"DTXCID9028251"
|